Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Hindawi Publishing CorporationInternational Journal of PediatricsVolume 2011, Article ID 461512, 11 pagesdoi:10.1155/2011/461512
Review Article
Exercise Interventions in Children with Cancer: A Review
Tseng-Tien Huang and Kirsten K. Ness
Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
Correspondence should be addressed to Kirsten K. Ness, [email protected]
Received 8 July 2011; Revised 3 September 2011; Accepted 3 September 2011
Academic Editor: Julie Blatt
Copyright © 2011 T.-T. Huang and K. K. Ness. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.
The purpose of this review is to summarize literature that describes the impact of exercise on health and physical functionamong children during and after treatment for cancer. Relevant studies were identified by entering the following search terms intoPubmed: aerobic training; resistance training; stretching; pediatric; children; AND cancer. Reference lists in retrieved manuscriptswere also reviewed to identify additional trials. We include fifteen intervention trials published between 1993 and 2011 thatincluded children younger than age 21 years with cancer diagnoses. Nine included children with an acute lymphoblastic leukemia(ALL) diagnosis, and six children with mixed cancer diagnoses. Generally, interventions tested were either in-hospital supervisedexercise training or home based programs designed to promote physical activity. Early evidence from small studies indicates thatthe effects of exercise include increased cardiopulmonary fitness, improved muscle strength and flexibility, reduced fatigue andimproved physical function. Generalizations to the entire childhood cancer and childhood cancer survivor populations are difficultas most of the work has been done in children during treatment for and among survivors of ALL. Additional randomized studiesare needed to confirm these benefits in larger populations of children with ALL, and in populations with cancer diagnoses otherthan ALL.
1. Introduction
Progress in treatments for childhood cancer have greatlyimproved cure rates, with 5-year survival now approaching80% [1]. This has resulted in a growing population ofchildhood cancer survivors. In 2006, there were more than11 million cancer survivors in the United States; three timesthe number of survivors in 1971 [2]. It is estimated that1 in 810 individuals under the age of 20 is a survivor ofchildhood cancer and that 1 in 640 individuals between theages of 20 and 39 years has successfully survived childhoodcancer [3]. Improving survival rates, however, does not comewithout consequences. Treatment of childhood cancer isassociated with a spectrum of late effects, including impairedgrowth and development, cognitive dysfunction, dimin-ished neurological function, cardiopulmonary compromise,musculoskeletal sequelae, and secondary malignancy [4–6].Oeffinger et al. [6] reported that one-third of childhoodcancer survivors have severe or life-threatening medicalcomplications 30 years after diagnosis. Therefore, attention
today is focused not only on survival but also on the qualityof survival.
Impaired physical fitness has been reported during andafter childhood cancer treatment [7–12]. Impaired physicalfitness typically includes reduced cardiopulmonary function,decreased muscle strength, fatigue, and altered physicalfunction. Treatments for childhood cancer, including radio-therapy, chemotherapy, and surgery, can result in acuteand long-term injury to the heart, lungs, and skeletalmuscles, systems necessary for optimal physical fitness [8,13–19]. Additionally, reduced levels of physical activityboth during and after treatment for childhood cancer cancontribute to cardiac deconditioning and skeletal muscleatrophy, ultimately limiting opportunities for participationin recreational activities and life roles that are dependenton adequate physical fitness. Exercise intervention has thepotential to improve cardiopulmonary and musculoskeletalfunction, perhaps preventing long-term deficits in physicalfitness if incorporated during or soon after treatment inchildren with cancer diagnoses [20–24].
2 International Journal of Pediatrics
Another factor that may be associated with impairedphysical fitness among childhood cancer survivors is cancer-related fatigue. Fatigue during and after treatment has thepotential to have a negative impact on physical activityand on psychosocial well-being. A recent study reportedthat the prevalence of cancer-related fatigue was over threetimes higher in long-term survivors of childhood cancerwhen compared to the general population (OR: 3.29; 95%CI: 1.9–5.70) [25]. In another investigation that evaluatedassociations between demographic and medical factors andhealth-related quality of life (HRQOL) among pediatriccancer survivors, Meeske et al. [26] found that fatigue was themost powerful predictor of functional status and HRQOL.Given that there is evidence that exercise and physical activityprograms can reduce fatigue, and enhance psychosocialhealth in survivors of adult cancer, such interventions mayhave a similar effect in the pediatric population [27].
This review of the literature indicates that there isgrowing evidence for the positive effects of physical trainingon organ system function, fatigue and physical well-beingin children during and after treatment for cancer [20,28]. However, the optimal intervention modality and theintensity, timing, and duration of the intervention aredifficult to determine. In the published literature, very fewexercise interventions undertaken in the pediatric cancer orpediatric cancer survivor populations have been randomizedclinical trials, and, across studies, the components of aerobictraining, resistance, and flexibility exercises are implementedwith differing intensity, timing, and duration. In addition,the sample sizes are small, limited primarily to studypopulations with acute leukemia diagnoses, and includewidely varied outcome measures, making it difficult to drawfirm conclusions or compare results between trials. We sum-marize here the literature that describes the effects of exerciseintervention on immune system function, cardiopulmonaryhealth, skeletal muscle strength, fatigue, and overall physicalwell-being among children during and after treatment forcancer.
2. Methods and Search Results
This paper summarizes exercise intervention studies amongchildren with cancer and is limited to studies that tested ordescribed exercise intervention in children diagnosed witha primary pediatric cancer when younger than 21 yearsof age, and, includes only manuscripts available as full-text in the English language. Studies were identified bysearching the PUBMED database with the terms exercise;aerobic training; resistance training; stretching; pediatric;children; cancer. Reference lists of retrieved studies werealso assessed to identify additional trials. The search of thePubmed database initially resulted in a total of 48 citations.Of these, we excluded 31 citations (3 review only, 5 notavailable in English, 17 no exercise intervention, and 6 adult-cancer survivors only). We include 17 published manuscriptsdocumenting 15 studies published by June of 2011. A reviewof the reference lists from the retrieved manuscripts did notidentify any additional papers. When reporting the outcomes
of each study, if numerical results were available, effectsizes were converted to Cohen’s d, representing standarddeviations of change or differences in standard deviationsbetween groups [29], to allow for easier comparison of themagnitude of the exercise intervention responses amongstudies.
2.1. Exercise Intervention Studies among Pediatric Survivors.A summary of the 15 published studies included in thisreview examining exercise intervention for children withcancer is shown in Tables 1 and 2. A total of 302 childrenwith cancer, survivors of childhood cancer, or normalcontrols participated in the 15 trials; 46 were young adults[30] and 256 were children or adolescents [21–23, 31–43]. Of these 15 exercise interventions during or afterpediatric cancer treatment, seven included a control groupor control intervention, nine employed supervised trainingwith aerobic, resistance, and/or flexibility training with orwithout home-based exercises [21–23, 31–40, 43], five testedenhanced physical activity (EPA) interventions [30, 34, 36,39, 42], and one used an individualized home-based exerciseprogram [41]. We differentiate between nonrandomized(Table 1) and randomized trials (Table 2) to highlight theneed for additional experimental evidence to evaluate theeffects of exercise intervention for children with cancer.Only 121 children with cancer diagnoses have participatedin four randomized controlled trials; 41 were children andadolescents with ALL during maintenance chemotherapy[21, 36] and 70 were the survivors of childhood cancerwith mixed diagnoses [33, 42]. We also differentiate betweenexercise and EPA by noting that exercise implies a specifictraining regimen with established frequency, intensity, andduration and that EPA includes dynamic activities completedduring the performance of everyday tasks [44]. The majorityof the interventions included only patients with acutelymphoblastic leukemia (ALL) diagnoses; only six studieswere done in study populations with mixed diagnoses [30,31, 34, 38, 39, 42]. One study was completed in children withALL during the first six months of medical treatment [32],and six were completed among children with ALL duringthe maintenance or continuation phase of medical treatment[21, 23, 35–37, 43]. Outcome measures described included(1) immunological function [31, 35], (2) cardiovascularfitness [21–23, 35, 36, 38, 40], (3) muscle strength andflexibility [21–23, 33, 34, 36, 40, 43], (4) fatigue or sleepefficacy [30, 34, 40–42], (5) general physical function [9, 21,32, 33, 36, 40], and (6) quality of life [9, 21, 32, 34, 39].
2.2. Effect of Exercise on Immune Suppression and GrowthFactors. Chemotherapy treatment for pediatric cancer sup-presses the immune system and may interfere with normalgrowth, increasing susceptibility to infection and stuntingor delaying musculoskeletal development during treatment[45–47]. Concern about the effects of exercise on immunefunction and growth factors includes the possibility thatexercise may tax an already compromised immune orendocrine system and either delay recovery or further impactnormal skeletal growth [48]. A pilot study by Ladha et al.
International Journal of Pediatrics 3
Ta
ble
1:D
escr
ipti
onof
non
-ran
dom
ized
exer
cise
tria
lsin
child
ren
wit
hca
nce
r.
Firs
tau
thor
and
year
Des
ign
Dem
ogra
phic
sE
xerc
ise
inte
rven
tion
(typ
eof
trai
nin
g,fr
equ
ency
,an
ddu
rati
on)
∗ Mai
nou
tcom
es
Shar
key,
1993
[38]
.P
rete
st/p
ostt
est
tria
l
N=
10.
Mix
edca
nce
rty
pes
.5
mal
es.M
ean
age
atth
eti
me
ofth
est
udy
:19±
3yr
s.
Inte
rven
tion
:aer
obic
trai
nin
gw
ith
hom
eex
erci
setw
ice
per
wee
k(w
eek
1-2
star
ted
wit
h15
min
ute
sof
war
m-u
p,15
min
ute
sof
exer
cise
at60
%of
HR
max
and
15m
inu
tes
ofco
ol-d
own
,wee
k3–
630
min
ute
sof
exer
cise
at70
–80%
HR
max
,an
dw
eek
7–12
30m
inu
tes
ofae
robi
cex
erci
seat
70–8
0%H
Rm
axpl
us
hom
eex
erci
seon
cep
erw
eek)
.D
ura
tion
:12
wee
ksof
out-
pati
ent
card
iac
reh
abili
tati
on.
Bod
yfa
t(−
),sp
irom
etry
(−),
pea
kh
eart
rate
(−),
pea
kox
ygen
upt
ake
(−),
anae
robi
cth
resh
old
(−),
peak
card
iac
inde
x(−
),p
eak
stro
kevo
lum
ein
dex
(−),
orva
scu
lar
resi
stan
ce(−
).E
xerc
ise
tim
e(+
13%
).
Ladh
a,20
06[3
5].
Non
ran
dom
ized
safe
tyas
sess
men
tw
ith
both
aca
nce
ran
da
hea
lthy
con
trol
popu
lati
ons.
Bot
hdi
dth
ein
terv
enti
on.
Can
cer
grou
p:N=
4.C
hild
ren
and
adol
esce
nts
rece
ivin
gm
ain
ten
ance
ther
apy
for
ALL
.M
ean
age
atth
eti
me
ofth
est
udy
:11.
3±
5.3
yrs.
Hea
lthy
con
trol
s:N=
6.M
ean
age
atth
eti
me
ofth
est
udy
:10.
8±
4.6
yrs
Inte
rven
tion
:on
ese
ssio
n(5
min
ute
sof
war
m-u
p,20
min
ute
sof
mod
erat
e-to
hig
h-i
nte
nsi
tyex
erci
se,a
nd
5m
inu
tes
ofco
ol-d
own
)of
inte
rmit
ten
tru
n-w
alk
ona
trea
dmill
at70
%to
85%
ofV
O2
pea
k.C
ontr
ols:
age-
mat
ched
hea
lthy
subj
ects
perf
orm
ing
the
sam
eex
erci
sein
terv
enti
on.
Du
rati
on:3
0m
inu
tes
ofac
ute
bou
tofe
xerc
ise
An
acu
tebo
ut
ofex
erci
sedi
dn
otel
icit
any
sign
ifica
nt
neg
ativ
eeff
ects
onn
eutr
oph
ilco
un
t.
San
Juan
,200
7[4
3]Sa
nJu
an,2
007
[23]
Ru
iz,2
010
[37]
Pre
test
/pos
ttes
ttr
ial
N=
7.C
hild
ren
rece
ivin
gm
ain
ten
ance
ther
apy
for
ALL
.4bo
ys.M
ean
age
atth
eti
me
ofth
est
udy
:5.
1±
1.2
yrs.
Inte
rven
tion
:th
ree
wee
kly
sess
ion
s(9
0–12
0m
inu
tes)
ofsu
perv
ised
resi
stan
cetr
ain
ing
(ben
chpr
ess,
shou
lder
pres
s,le
gex
ten
sion
,le
gcu
rl,l
egpr
ess,
abdo
min
alcr
un
ch,
low
er-b
ack
exte
nsi
on,a
rmcu
rl,e
lbow
exte
nsi
on,s
eate
dro
w,a
nd
late
ralp
ull-
dow
n;
8–15
rep
etit
ion
s)an
dae
robi
cex
erci
se(s
tart
edw
ith
10m
inu
tes
ofex
erci
ses
at50
%of
age-
pred
icte
dH
Rm
axan
dpr
ogre
ssed
to30
min
ute
sof
con
tin
uou
sex
erci
seat≥7
0%H
Rm
axby
the
end
ofth
epr
ogra
m).
Du
rati
on:1
6w
eeks
plu
s20
wee
ksof
detr
ain
ing,
duri
ng
trea
tmen
t
VO
2pe
ak(+
),V
T(+
),fu
nct
ion
alm
obili
ty(+
)(T
UD
s,3-
and
10-m
eter
TU
G)
and
stre
ngt
hte
sts
(+)
(sea
ted
ben
chpr
ess,
seat
edro
w,a
nd
seat
edle
gpr
ess)
from
befo
retr
ain
ing
toaf
ter
trai
nin
g.O
nly
incr
ease
dst
ren
gth
rem
ain
edsi
gnifi
can
taf
ter
detr
ain
ing.
An
kle
dors
iflex
ion
ran
geof
mot
ion
(−)
orQ
OL
(−).
Leve
lsof
grow
thho
rmon
e(−
),in
sulin
-lik
egr
owth
fact
ors
(−),
and
insu
lin-l
ike
grow
thbi
ndi
ng
prot
ein
s(−
).
4 International Journal of PediatricsT
abl
e1:
Con
tin
ued
.
Firs
tau
thor
and
year
Des
ign
Dem
ogra
phic
sE
xerc
ise
inte
rven
tion
(typ
eof
trai
nin
g,fr
equ
ency
,an
ddu
rati
on)
∗ Mai
nou
tcom
es
Kea
tsan
dC
ulo
s-R
eed,
2008
[34]
.P
rete
st/p
ostt
est
tria
l.N=
10.A
dole
scen
tsw
ith
can
cer.
2m
ales
.Mea
nag
eat
the
tim
eof
the
stu
dy:1
6.2±
1.6
(ran
ge14
–18)
yrs
Inte
rven
tion
:phy
sica
lact
ivit
yan
ded
uca
tion
alin
terv
enti
on(3
0m
inu
tes
ofed
uca
tion
alse
ssio
n,4
5m
inu
tes
ofae
robi
ctr
ain
ing,
and
15m
inu
tes
ofco
rest
ren
gth
and
flex
ibili
tytr
ain
ing
inth
efi
rst
8w
eeks
;ava
riet
yof
non
com
peti
tive
phys
ical
acti
viti
esin
the
fin
al8
wee
ks)
Du
rati
on:1
6w
eeks
,agr
oup-
base
dph
ysic
alac
tivi
tyin
terv
enti
on.
Att
enda
nce
rate
:81.
5%ov
er16
-wee
kin
terv
enti
on.
Upp
erbo
dyst
ren
gth
(+),
flex
ibili
ty(+
),to
talP
A(+
),Q
OL
(+),
and
gen
eral
fati
gue
(+).
Part
icip
ants
faile
dto
mai
nta
inth
eir
post
inte
rven
tion
PAle
vels
atbo
th3-
and
12-m
onth
follo
w-u
pti
me
poi
nts
.
San
Juan
,200
8[2
2].
Pre
test
/pos
ttes
ttr
ial.
N=
8.C
hild
ren
afte
rH
CT
for
leu
kem
ia.4
boys
.M
ean
age
atth
eti
me
ofth
est
udy
:10.
9±
2.8
yrs.
Inte
rven
tion
:th
ree
wee
kly
sess
ion
s(9
0–12
0m
inu
tes)
ofsu
perv
ised
resi
stan
cetr
ain
ing
(ben
chpr
ess,
shou
lder
pres
s,le
gex
ten
sion
,le
gcu
rl,l
egpr
ess,
abdo
min
alcr
un
ch,
low
er-b
ack
exte
nsi
on,a
rmcu
rl,e
lbow
exte
nsi
on,s
eate
dro
w,a
nd
late
ralp
ull-
dow
n;
11re
peti
tion
s)an
dae
robi
cex
erci
se(s
tart
edw
ith
10m
inu
tes
ofex
erci
ses
at50
%of
age-
pred
icte
dH
Rm
axan
dpr
ogre
ssed
to30
min
ute
sof
con
tin
uou
sex
erci
seat≥7
0%H
Rm
axby
the
end
ofth
epr
ogra
m)
Du
rati
on:8
wee
ks,d
uri
ng
trea
tmen
t
Mu
scle
stre
ngt
h(+
),V
O2
pea
k(+
),fu
nct
ion
alm
obili
ty(+
)(T
UD
s,3-
and
10-m
eter
TU
G)
and
self
-rep
orte
dh
ealt
hst
atu
s(+
).B
MI
(−),
acti
vean
dpa
ssiv
edo
rsifl
exio
nra
nge
ofm
otio
n(−
),V
T(−
),or
Hm
ax(−
).
Takk
en,2
009
[40]
.P
rete
st/p
ostt
est
tria
l.N=
9.C
hild
ren
wit
hA
LL.M
ean
age
atth
eti
me
ofth
est
udy
:9.3±
3.2
(ran
ge6–
14)
yrs
Inte
rven
tion
:tw
ow
eekl
yse
ssio
ns
(45
min
ute
s)of
supe
rvis
edre
sist
ance
trai
nin
g(s
it-u
ps,p
ush
-ups
,hea
dan
dle
gra
ises
;30
-sec
ond
repe
titi
onm
axim
um
and
squ
ats
60-s
econ
dre
peti
tion
max
imu
m),
aero
bic
exer
cise
(66–
77%
ofH
Rm
axin
firs
t4
wee
ks,
77–9
0%H
Rm
axin
the
follo
win
g4
wee
ks,
and≥9
0%H
Rm
axin
the
last
4w
eeks
)an
da
hom
e-ba
sed
exer
cise
prog
ram
(str
engt
h,
flex
ibili
ty,a
nd
aero
bic
fitn
ess)
.D
ura
tion
:12
wee
ks,c
omm
un
ity-
base
dex
erci
sepr
ogra
m
Seve
nty
per
cen
tof
trai
ner
sw
ere
sati
sfied
wit
hth
epr
ogra
m.B
MI
(−),
mu
scle
stre
ngt
h(−
),ex
erci
seca
paci
ty(−
),fu
nct
ion
alm
obili
ty(−
),or
fati
gue
leve
ls(−
).
Bla
auw
broe
k,20
09[3
0].
Pre
test
/pos
ttes
ttr
ial.
N=
38.A
dult
surv
ivor
sof
child
hoo
dca
nce
r(m
ixed
can
cer
type
s).1
4m
ales
.Age
atdi
agn
osis
8.1±
6.7
year
s;ti
me
sin
cedi
agn
osis
21.8±
7.1
year
s.M
ean
age
atth
eti
me
ofth
est
udy
:29.
8±
8.6
yrs
Inte
rven
tion
:en
han
ced
phys
ical
acti
vity
(su
chas
wal
kin
g,cy
clin
g,h
ouse
keep
ing,
and
gard
enin
g)co
un
selin
g.T
he
cou
nse
lor
enco
ura
ged
the
surv
ivor
sto
chan
geth
eir
lifes
tyle
and
enh
ance
daily
phys
ical
acti
vity
tom
eet
publ
ish
edex
erci
segu
idel
ines
(i.e
.,at
leas
t15
0m
inu
tes
ofm
oder
ate-
to-v
igor
ous
exer
cise
/wee
k)an
dph
oned
the
surv
ivor
sat
thre
ew
eeks
,six
wee
ks,a
nd
nic
ew
eeks
toch
eck
goal
s.Fe
edba
ckfr
oma
ped
omet
er.
Du
rati
on:1
0w
eeks
ofco
un
selin
g.
Sign
ifica
nt
impr
ovem
ents
infa
tigu
ean
dda
ilyst
eps
afte
rin
terv
enti
on.T
her
ew
asa
low
corr
elat
ion
(0.1
2)be
twee
nin
crea
sein
daily
step
san
dth
ede
crea
sein
fati
gue.
International Journal of Pediatrics 5T
abl
e1:
Con
tin
ued
.
Firs
tau
thor
and
year
Des
ign
Dem
ogra
phic
sE
xerc
ise
inte
rven
tion
(typ
eof
trai
nin
g,fr
equ
ency
,an
ddu
rati
on)
∗ Mai
nou
tcom
es
Spey
er,2
010
[39]
.C
ross
-ove
r,si
ngl
est
udy
desi
gn.
N=
30.C
hild
ren
wit
hca
nce
r(h
emat
olog
icm
alig
nan
cy:1
5,so
lidtu
mor
s:12
,un
know
n:3
).18
mal
es.M
ean
age
atth
eti
me
ofth
est
udy
:13.
6±
2.9
yrs.
Inte
rven
tion
:th
ree
wee
kly
sess
ion
s(3
0m
inu
tes)
ofad
apte
dph
ysic
alac
tivi
ty(b
all
gam
es,c
ircu
sar
ts,t
hro
win
gga
mes
,sh
ooti
ng
gam
es,r
acke
tsp
orts
,vid
eoga
mes
,an
dbo
dybu
ildin
g).
Con
trol
:sta
nda
rdca
rew
ith
out
adap
ted
phys
ical
acti
vity
.D
ura
tion
:fou
rp
erio
dsof
enh
ance
dph
ysic
alac
tivi
ty(c
ross
-ove
r).
QO
Lsc
ores
inph
ysic
alan
dps
ych
olog
ical
dim
ensi
ons
wer
eh
igh
erfo
rth
ech
ildre
nw
ho
prac
tice
dth
anfo
rth
ose
wh
odi
dn
otpr
acti
cead
apte
dph
ysic
alac
tivi
tydu
rin
gh
ospi
taliz
atio
n.
Ch
amor
ro-V
ina,
2010
[31]
.N
onra
ndo
miz
edco
ntr
olle
dtr
ial.
Inte
rven
tion
grou
p:N=
7.C
hild
ren
wh
oh
adu
nde
rgon
eH
CT.
5bo
ys.M
ean
age
atth
eti
me
ofth
est
udy
:8±
4yr
s.C
ontr
olgr
oup:N=
13.9
boys
.Mea
nag
eat
the
tim
eof
the
stu
dy:7±
3yr
s.
Inte
rven
tion
:Fiv
ew
eekl
yse
ssio
ns
( ∼50
min
ute
s)of
supe
rvis
edre
sist
ance
trai
nin
g(a
rmcu
rl,e
lbow
exte
nsi
on,b
ench
pres
s,lo
gex
ten
sion
,hal
fsqu
at,a
bdom
inal
cru
nch
,su
pin
ebr
idge
,an
dro
win
g;12
–15
repe
titi
ons)
(str
etch
ing
exer
cise
invo
lvin
gal
lmaj
orm
usc
legr
oups
)an
dae
robi
cex
erci
se(1
0–40
min
ute
sof
cycl
eer
gom
etry
at50
%to
70%
ofH
Rm
ax).
Con
trol
:sta
nda
rdca
re.
Du
rati
on:3
wee
ks,d
uri
ng
trea
tmen
t.
Fitn
ess
leve
ls(+
)(h
alf
squ
at)
orbo
dym
ass
(+).
Exe
rcis
ein
terv
enti
ondu
rin
gin
pati
ent
stay
for
HC
Tdi
dn
otaff
ect
imm
un
ece
llre
cove
ryin
you
ng
child
ren
wit
hh
igh
-ris
kca
nce
r.
Yeh
,201
1[4
1].
Non
ran
dom
ized
con
trol
led
tria
l.
Inte
rven
tion
grou
p:N=
12.C
hild
ren
and
adol
esce
nts
wit
hA
LL.6
boys
.Mea
nag
eat
the
tim
eof
the
stu
dy:1
1±
4yr
s.C
ontr
olgr
oup:
N=
10.6
boys
.Mea
nag
eat
the
tim
eof
the
stu
dy:
12.5±
4yr
s.
Inte
rven
tion
:th
ree
wee
kly
sess
ion
s(3
0m
inu
tes)
ofin
divi
dual
ized
hom
e-ba
sed
aero
bic
exer
cise
prog
ram
(exe
rcis
ein
ten
sity
:40
%–6
0%of
HR
R)
Con
trol
:sta
nda
rdca
reD
ura
tion
:6w
eeks
,du
rin
gtr
eatm
ent
Gen
eral
fati
gue
(+).
Slee
p/re
stan
dco
gnit
ive
fati
gue
scor
es(−
).
Goh
ar,2
011
[32]
.P
rete
st/p
ostt
est
tria
l.N=
9.C
hild
ren
wit
hA
LL.3
mal
es.M
edia
nag
eat
tim
eof
the
stu
dy:4
(ran
ge2–
14)
yrs
Inte
rven
tion
:in
divi
dual
ized
hom
e-ba
sed
exer
cise
prog
ram
(str
etch
ing
exer
cise
:an
kle
dors
iflex
ion
;5da
ys/w
eek,
stre
ngt
hen
ing
exer
cise
:low
er-
and
upp
er-e
xtre
mit
yex
erci
se;
10re
peti
tion
s5
days
/wee
k,an
dae
robi
cex
erci
se:w
alki
ng,
bike
ridi
ng,
and
dan
cin
g10
–30
min
ute
s;5
days
/wee
k).
Du
rati
on:6
-7m
onth
s,du
rin
gtr
eatm
ent.
Gro
ssm
otor
fun
ctio
n(+
)an
dQ
OL
mea
sure
s(+
)th
rou
ghou
tth
est
udy
(at
diag
nos
is,i
ndu
ctio
n,
con
solid
atio
n,i
nte
rim
mai
nte
nan
ce,a
nd
dela
yed
inte
nsi
fica
tion
).H
owev
er,
QO
Lsc
ores
decr
ease
dfr
omin
teri
mm
ain
ten
ance
tode
laye
din
ten
sifi
cati
on.T
he
pare
nts
repo
rted
bein
gsa
tisfi
edw
ith
the
PT
prog
ram
.∗
(+)
toin
dica
tea
sign
ifica
nt
effec
t;(−
)to
indi
cate
no
sign
ifica
nt
effec
t/ch
ange
.A
LL:
acu
tely
mph
obla
stic
leu
kem
ia;
AM
L:ac
ute
mye
loid
leu
kem
ia;
BM
D:
bon
em
iner
alde
nsi
ty;
BM
I:bo
dym
ass
inde
x;C
NS:
cen
tral
ner
vou
ssy
stem
;H
RR
:h
eart
rate
rese
rve;
HC
T:
hem
atop
oiet
icst
emce
lltr
ansp
lan
t;PA
:phy
sica
lact
ivit
y;P
T:p
hysi
calt
her
apy;
QO
L:qu
alit
yof
life;
VO
2pe
ak:p
eak
aero
bic
fitn
ess;
HR
max
:max
imu
mof
hea
rtra
te;T
UD
s:ti
me
up
and
dow
nst
air
test
;TU
G:t
imed
up
and
gote
st;V
T:
ven
tila
tory
thre
shol
d.
6 International Journal of Pediatrics
Ta
ble
2:D
escr
ipti
onof
the
ran
dom
ized
exer
cise
tria
lsin
child
ren
wit
hca
nce
r.
Firs
tau
thor
and
year
Dem
ogra
phic
sE
xerc
ise
inte
rven
tion
(typ
eof
trai
nin
g,fr
equ
ency
,an
ddu
rati
on)∗ M
ain
outc
omes
Mar
ches
e,20
04[2
1].
Inte
rven
tion
grou
p:N=
13.
ALL
rece
ivin
gm
ain
ten
ance
ther
apy.
8m
ales
.M
ean
age
atth
eti
me
ofth
est
udy
:7.6
(ran
ge,
4.3–
10.6
)yr
s.C
ontr
olgr
oup:N=
15.
12m
ales
.M
ean
age
atth
eti
me
ofth
est
udy
:8.6
(ran
ge5.
1–15
.8)
yrs
Inte
rven
tion
:five
sess
ion
s(2
0to
60m
inu
tes
imm
edia
tely
afte
rin
itia
ltes
tin
g,an
d2,
4,8,
and
12w
eeks
late
r)of
PT
(str
etch
ing
and
stre
ngt
hen
ing
exer
cise
s,su
perv
ised
)an
dan
indi
vidu
aliz
edh
ome-
base
dex
erci
sepr
ogra
m(b
ilate
rala
nkl
edo
rsifl
exio
nst
retc
hin
gfo
r30
sec
5da
ysp
erw
eek,
bila
tera
llow
erex
trem
ity
stre
ngt
hen
ing
3se
ts,3
days
per
wee
k,an
dae
robi
cex
erci
ses)
.C
ontr
ol:n
oin
stru
ctio
ns
rela
ted
toph
ysic
alfi
tnes
san
dn
oP
Tin
terv
enti
on.
Du
rati
on:1
6w
eeks
,du
rin
gtr
eatm
ent.
Hem
oglo
bin
leve
l(−)
,an
kle
dors
iflex
ion
stre
ngt
h(−
),T
UD
s(−
),9-
min
ute
wal
k-ru
n(−
),an
dQ
OL
(−).
An
kle
dors
iflex
ion
ran
geof
mot
ion
(act
ive)
and
knee
exte
nsi
onst
ren
gth
incr
ease
din
inte
rven
tion
grou
pfr
ombe
fore
toaf
ter
test
.
Hin
ds,2
007
[42]
.
Inte
rven
tion
grou
p:N=
14.C
hild
ren
and
adol
esce
nts
wit
hca
nce
r.9
mal
es.M
ean
age
atth
eti
me
ofth
est
udy
:13.
0(r
ange
8.5–
17.4
)yr
sC
ontr
olgr
oup:N=
15.3
mal
es.M
ean
age
atth
eti
me
ofth
est
udy
:11.
9(r
ange
7.4–
18.1
)yr
s
Inte
rven
tion
:en
han
ced
phys
ical
acti
vity
(ped
alin
ga
stat
ion
ary
bike
-sty
leex
erci
ser,
30m
inu
tes,
twic
eda
ilydu
rin
gbr
ief
hos
pita
lizat
ion
).C
ontr
ol:s
tan
dard
care
.D
ura
tion
:2–4
days
,du
rin
gtr
eatm
ent.
Slee
peffi
cien
cy(+
).
Moy
er-M
ileu
r,20
09[3
6].
Inte
rven
tion
grou
p:N=
6.C
hild
ren
rece
ivin
gm
ain
ten
ance
ther
apy
for
ALL
.3m
ales
.Mea
nag
eat
the
tim
eof
the
stu
dy:7
.2±
0.7
yrs.
Con
trol
grou
p:N=
7.4
mal
es.M
ean
age
atth
eti
me
ofth
est
udy
:5.9±
0.7
yrs.
Inte
rven
tion
:an
indi
vidu
aliz
edex
erci
sepr
ogra
m(t
hre
e15
–20-
min
ute
sess
ion
sof
mod
erat
e-to
-vig
orou
sac
tivi
typ
erw
eek)
and
nu
trit
ion
aled
uca
tion
.C
ontr
ol:r
ecei
ved
stan
dard
diet
reco
mm
enda
tion
and
perf
orm
edac
tivi
tyas
tole
rate
d.D
ura
tion
:12
mon
ths,
enh
ance
dph
ysic
alac
tivi
typr
ogra
m
Nu
trie
nt
inta
ke(−
),h
eigh
t(−
),w
eigh
t(−
),or
BM
I(−
)be
twee
nin
terv
enti
onan
dco
ntr
olgr
oups
.No
inte
rven
tion
effec
tfo
ru
pper
body
stre
ngt
h(p
ush
-up
com
plet
ed)
orfl
exib
ility
(sit
and
reac
hdi
stan
ce).
Self
-rep
orte
dPA
(+)
and
aca
rdio
vasc
ula
rfi
tnes
s(+
).
Har
tman
,200
9[3
3].
Inte
rven
tion
grou
p:N=
25.
Ch
ildre
nw
ith
ALL
.14
boys
.Med
ian
age
atth
eti
me
ofth
est
udy
:5.3
(ran
ge1.
3–15
.6)
yrs.
Con
trol
grou
p:N=
26.1
6bo
ys.M
edia
nag
eat
the
tim
eof
the
stu
dy:6
.2(r
ange
1.7–
17.1
)yr
s.
Inte
rven
tion
:pre
ven
tive
PT
prog
ram
(wee
kly
stre
ngt
hen
ing
and
stre
tch
ing
exer
cise
and
shor
t-bu
rst
hig
h-i
nte
nsi
tyex
erci
sein
BM
Dtw
ice
per
wee
k).
Con
trol
:sta
nda
rdca
re.
Du
rati
on:2
year
s,du
rin
gtr
eatm
ent.
Perc
enta
geof
body
fat
(−)
orle
ssbo
dym
ass
(−).
BM
Dde
crea
sed
sign
ifica
ntl
yin
both
grou
psbe
twee
nth
est
art
and
end
oftr
eatm
ent.
Mot
orp
erfo
rman
ce(−
)or
ankl
edo
rsifl
exio
nra
nge
ofm
otio
n(−
)be
twee
ngr
oups
.∗
(+)
toin
dica
tea
sign
ifica
nt
effec
t;(−
)to
indi
cate
no
sign
ifica
nt
effec
t/ch
ange
.A
LL:a
cute
lym
phob
last
icle
uke
mia
;BM
D:b
one
min
eral
den
sity
;BM
I:bo
dym
ass
inde
x;PA
:phy
sica
lact
ivit
y;P
T:p
hysi
calt
her
apy;
QO
L:qu
alit
yof
life;
TU
Ds:
tim
eu
pan
ddo
wn
stai
rte
st.
International Journal of Pediatrics 7
[35] investigated the effects of an acute bout (30 minutes) ofexercise (heart rate 70–85% of peak oxygen uptake capacity(VO2 peak)) on neutrophil counts and immune functionin children undergoing maintenance therapy for ALL (n =4; mean age 11.3 ± 5.3 years). They found no deleteriouseffects of this intervention on immune function. Their workis supported by Chamorro-Vina et al. who demonstratedthat a daily 3-week in-hospital moderate intensity exercisetraining regimen, including both supervised resistance andaerobic components, did not affect immune cell recoveryin 7 children who had undergone hematopoietic stemcell transplantation [31]. This same group of authors alsoreport no significant impact of a 3 times per week 16-week aerobic and resistance training intervention on levelsof growth hormone, insulin-like growth factors, and insulin-like growth binding proteins levels (IGFBP-2 and -3) [37]in children with ALL. In this study, protein levels of IGFBPsremained stable even after 20 weeks of detraining.
2.3. Effect of Exercise on the Cardiopulmonary System. Cardi-opulmonary fitness is impaired in children during treatmentand among survivors of childhood cancer [9, 10]. Reports ofthe effects of exercise intervention on the cardiopulmonarysystem during treatment are mixed. Marchese et al. [21]examined effects of exercise on cardiovascular response inchildren (aged 4–15 years) receiving maintenance therapyfor ALL. Participants were randomly assigned into a physicaltherapy (PT) intervention group with home-based aerobictraining two times per week (n = 13) or a control (non-PT intervention) group (n = 15). Following a four-monthintervention, these authors reported no cardiopulmonaryresponse to training as assessed by a nine minute run-walk test. Additionally, more than 50% of the childrenscored below the 25th percentile for cardiopulmonary fitnesswhen compared to the normative sample in the AmericanAlliance of Health, Physical Education, Recreation andDance Association Guidelines at both the pre- and posttestassessments. Similarly, Takken et al. [40] implemented a12-week community-based exercise program in 9 childrenwith ALL (aged 6–14 years) and found no cardiopulmonaryresponse to training as assessed by standardized cardiopul-monary exercise testing. Of note, some children in thisstudy complained that the training program was boring,too intense, and hard to combine with their other activitieswhich may have limited compliance. Moyer-Mileur et al.[36], who provided a home-based intervention to childrenwith ALL during the maintenance phase of chemotherapy,report slightly more promising results. In a much longerduration intervention, with a perhaps more palatable inten-sity of training, they assigned thirteen 4–10-year-old childrento either 15–20 minutes of moderate to vigorous physicalactivity 3 times per week (n = 6) or to no intervention(n = 7). After 12 months, regular physical activity andcardiopulmonary fitness were assessed with a pedometer anda Progressive Aerobic Cardiovascular Endurance Run test(PACER) [49], respectively. The authors reported that theexercise group recorded more steps on the pedometer (P =0.06, Cohen’s d = 1.12) and performed slightly better on the
PACER (P = 0.05, Cohen’s d = 1.22) than the control groupat the end of the intervention.
It appears that hospital type supervised exercise inter-ventions have better cardiopulmonary outcomes than dothose that are home or community based. San Juan et al. [9]reported positive results after implementation of a 16-weeksupervised (in-person) exercise program among 7 childrenwith ALL, 4–7 years of age, also during the maintenancephase of chemotherapy. Their study population achieveda significant increase in both ventilatory threshold (beforetraining 15.8 ± 3.3; after training 20.7 ± 2.9 milliliters perkilogram per minute (mL/kg/min), P < 0.05, Cohen’s d =1.58) and peak oxygen uptake (before training 24.3 ± 5.9;after training 30.2 ± 6.2 mL/kg/min, P < 0.05, Cohen’sd = 0.97). A subsequent study by San Juan et al. [9] showedsimilar benefits for an 8-week supervised exercise trainingprogram among 8 children after HCT.
Supervised exercise training also appears to have promisefor childhood cancer survivors with long-term cardiopul-monary compromise. A study by Sharkey et al. [38] exam-ined the effects of a 12-week aerobic training programamong childhood cancer survivors who had been treatedwith anthracycline chemotherapy (cumulative dosage 349 ±69 milligrams per meter squared (mg/m2)). Among the 10patients who completed the twice weekly program (mean age19 ± 3 years; mean time since diagnosis 8 ± 4 years), therewas an average increase in exercise time on cardiopulmonaryexercise testing (CPET) of 13 percent (%) from before toafter test (P < 0.05, Cohen’s d = 0.47). They also reporteda trend toward improvement in peak oxygen uptake (P =NS, Cohen’s d = 0.36) and anaerobic threshold (P = NS,Cohen’s d = 0.58), but no significant changes in bodyfat, spirometer parameters, cardiac index, or stroke volumeindex. Unfortunately, although these 10 participants showedsome improvement in exercise tolerance, their exercisecapacity remained substantially lower than those of normalsubjects.
2.4. Effect of Exercise on the Musculoskeletal System. Cancertherapy in children also impacts the musculoskeletal system.Limited range of motion, loss of muscle mass, and reducedmuscle strength are common among children with cancerand among survivors [33, 50–52]. Fortunately, the earlyintervention research targeting these impairments is verypromising. Improved muscle strength and flexibility isreported following training among children during mainte-nance therapy for ALL [9, 21] and in groups of children withmixed cancer diagnoses [34]. In their 12-week home-basedPT intervention for children during maintenance therapy forALL (n = 13 intervention group, n = 15 control group),Marchese et al. [21] reported that stretching and resistancetraining improved ankle range of motion (P < 0.01, Cohen’sd = 0.62) and knee extension strength (P < 0.01, Cohen’sd = 0.35). In another intervention during ALL maintenancetherapy among 7 children 4–7 years of age, San Juan et al. [9]implemented resistance training for the major muscle groupsand reported muscle strength gains (P < 0.05, Cohen’s d =0.85 to 1.48) after just eight weeks of training [9]. These gains
8 International Journal of Pediatrics
were maintained after a 20-week detraining period [9]. In alonger intervention program (2 years) designed to preventbone loss in children during treatment for ALL (interventiongroup n = 25, control group n = 26) Hartman et al. [33]reported that stretching and twice daily short-burst high-intensity exercise resulted in improved dorsiflexion range ofmotion (P = 0.001, Cohen’s d = 0.94), but not in improvedbone health. In a group-based physical activity interventionwith a group of adolescent cancer survivors with mixeddiagnoses (n = 10), Keats and Culos-Reed [34] reportedimproved upper body strength (P < 0.05, Cohen’s d = 0.64)after 16 weeks of participation.
2.5. Effect of Exercise on Fatigue. Fatigue is a commonsymptom in children during and following cancer treatment[53, 54]. Both exercise and EPA type interventions showsome efficacy in the management of fatigue during andafter cancer chemotherapy in children [30, 34]. However,it appears that fatigue reduction also requires a trainingresponse. In three studies, where the response to training waspositive, fatigue reduction was evident and even persisted,whereas in one study, where the exercise response was null,so was the fatigue reduction response. Yeh et al. [41] reportedreduced levels of fatigue (P = 0.03, Cohen’s d = 0.54)among children with ALL (n = 12) who completed a six-week home-based aerobic exercise program when comparedto a control group who did not (n = 10), and Blaauwbroeket al. [30] reported reduced levels of fatigue (P < 0.005,Cohen’s d = −0.92) and increased levels of physical activity(P < 0.005, Cohen’s d = 0.94) after 10 weeks of a home-based physical activity counseling intervention in childhoodcancer survivors. The Blaauwbroek study was implementedin survivors (n = 38) who were on average 30 yearsof age and 22 years from their original cancer diagnosis.Importantly, fatigue reduction was maintained in their studypopulation at a three-year follow-up time point. The resultsof a study by Keats and Culos-Reed [34] also demonstrateda reduction in fatigue (P = 0.01, Cohen’s d = 0.69)after a 16-week group-based physical activity intervention insurvivors of pediatric cancer (n = 10). In contrast, a 12-weekcommunity-based exercise training program where there wasno exercise response, perhaps because of noncompliance,also demonstrated no fatigue reduction response (P = NS,Cohen’s d = −0.26) [40].
2.6. Effect of Exercise on General Physical Functioning. Sup-pressed immune system function, poor cardiopulmonaryfitness, reduced muscle strength, and fatigue may decreasethe ability of a child with cancer or a childhood cancer sur-vivor to participate comfortably in regular physical activity.Implementation of a program of exercise or EPA, on theother hand, may improve their strength and fitness and, if italleviates fatigue, may increase ease of movement and enableactivities that have a physical component. The evidence forefficacy of exercise and EPA programs to improve overallphysical functioning and mobility in survivors of pediatriccancer is mixed. Among children with ALL, four differentexercise intervention studies have documented the beneficial
effects of a supervised training program or home-basedexercise [9, 32] on general physical functioning, whereasthree other studies have failed to find a positive effectof exercise on physical functioning [21, 33, 40]. Like theimpact of exercise on fatigue, the impact of exercise onphysical functioning appears to require that the interventionhave a training effect. San Juan et al. in their series ofthree manuscripts (n = 7) demonstrated that a supervisedtraining program among young children with ALL or inchildren following HCT, consisting of both resistance andaerobic exercises, improved not only muscle strength andcardiopulmonary fitness but also functional mobility asassessed by performance on three and ten meter timedup and go (TUG) tests (Cohen’s d −0.63 to −1.53, P <0.05) [9]. Gohar et al. [32] reported improved gross motorfunction in nine children after implementing individualizedhome-based exercise programs during the early phases oftreatment for ALL in nine children. However, the twelve-week supervised community-based intervention by Takkenet al. [40] among 9 children during the maintenance phaseof ALL treatment that had no training effect also had noimpact on functional mobility. Additionally, Marchese et al.[21], who demonstrated improvements in ankle range ofmotion and knee extension strength, but no improvementsin cardiopulmonary fitness (P = 0.25, Cohen’s d = 0.57)after implementation of a 16-week home program duringmaintenance therapy for children (intervention group n =13, control group n = 15) with ALL, also reported noimprovements in performance on the TUG test (P = 0.17,Cohen’s d = −0.55).
2.7. Effect of Exercise on Health-Related Quality of Life. Sixof the studies we reviewed reported a health-related qualityof life outcome (HRQOL) in response to exercise trainingor EPA [9, 21, 32, 34, 39]. Four reported a positive effectand two no effect. Positive effects were found in threestudies with no control population, making it difficult toattribute the outcomes to the intervention rather than todevelopmental maturation or disease recovery. Gohar et al.[32] and Speyer et al. [39] both report overall improvementin HRQOL in response (P < 0.001, Cohen’s d = 1.43 to 2.32)to an individualized home-based exercise intervention [32]or to an in-hospital adapted physical activity intervention[39] among children during acute phases of treatment.Interestingly, the study by Gohar et al. [32] reported an initialreduction in HRQOL when chemotherapy was intensifiedduring treatment among 9 children with ALL. San Juan etal. [9] also reported improved HRQOL (P < 0.05, Cohen’sd = 1.1) in response to their 8-week long supervised exerciseintervention among 8 children following HCT, and Keatsand Culos-Reed [34], in a group of 10 adolescent cancersurvivors with mixed diagnoses, reported improved HRQOL(P = 0.01, Cohen’s d = 0.34) after a sixteen-week physicalactivity and educational intervention. These results in theadolescent survivors of mixed diagnoses persisted for at leastone year following the end of the intervention. In contrast tothe results of their study among children following HCT, SanJuan et al. reported no effect of exercise training on HRQOL
International Journal of Pediatrics 9
(P = NS, Cohen’s d = 0.31 to 0.58) among 7 children whoreceived 16-week supervised exercise intervention duringmaintenance therapy for ALL [9]. This finding is similar tothat of Marchese et al., who also reported no differencesbetween the intervention (n = 13) and control (n = 15)groups on HRQOL in their study of the effects of a 16-week home-based PT intervention among children duringmaintenance therapy for childhood ALL [21].
3. Conclusion
It appears that exercise training can be safely undertakenduring treatment for ALL and HCT with no major effects onthe immune system and that exercise does not have a dele-terious effect on growth factors during treatment for ALL.The published evidence is positive for the impact of exerciseon muscle strength and flexibility and mixed for the impactof exercise intervention on cardiopulmonary fitness amongchildren with ALL during maintenance therapy, amongchildren following HCT, and among survivors exposed tocardiotoxic agents. Fatigue and general physical function areenhanced if the intervention generates a cardiopulmonarytraining effect. The evidence for the effects of exercisetraining on HRQOL in the childhood cancer population ismixed and difficult to disentangle from the effects of diseaserecovery and normal maturation. The early evidence suggeststhat supervised hospital training is effective, likely becausecompliance and training intensity are assured. Home- orcommunity-based programs appear to be less effective.Unfortunately, supervised training is expensive and oftenunrealistic for families who may have to travel long distancesto a center that specializes in cancer care.
Even though early results are promising, specific limi-tations in the existing literature do not allow us to yet beable to state with confidence that exercise interventions offerclear benefits during or after treatment for childhood cancer.There have only been four randomized trials, sample sizeshave been small, and diagnosis groups included in the trialshave been very limited (mostly ALL). Intent to treat typeof analysis has not always been completed, and mechanismsto characterize the effects of participant dropout have notbeen employed. In addition, inconsistencies in exercisetype, duration, and frequency, and outcome measurementprohibit conclusions that might guide how an individualclinician might prescribe exercise in practice.
Further research is needed. Studies designed to identifyand characterize the type and intensity of exercise necessaryto achieve clinically meaningful positive cardiopulmonary,musculoskeletal, symptom limiting, physical function, andquality of life outcomes in children with a variety of diag-noses are necessary. These interventions must be not onlysafe but also realistic and portable so that children, families,and long-term survivors can adopt and incorporate exerciseand physical activity into their everyday lives when they arenot near the specialized center that provides care for childrenwith cancer. Additionally, larger well-designed randomizedstudies that employ strong statistical methodology and thatevaluate the effects of participant dropout on the outcomes
are important to see if the early results from these multiplesmall, mostly observational trials remain positive in largerpopulations of children with varied cancer diagnoses.
References
[1] M. A. Smith, N. L. Seibel, S. F. Altekruse et al., “Outcomesfor children and adolescents with cancer: challenges for thetwenty-first century,” Journal of Clinical Oncology, vol. 28, no.15, pp. 2625–2634, 2010.
[2] T. Hampton, “Cancer survivors need better care: new reportmakes recommendations,” Journal of the American MedicalAssociation, vol. 294, no. 23, pp. 2959–2960, 2005.
[3] S. B. J. Bhatia and A. T. Meadows, “Late effects of childhoodcancer and its treatment,” in Principles and Practice of PediatricOncology, P. D. Pizzo Pa, Ed., pp. 1490–1514, LippincottWilliams & Wilkins, Philadelphia, Pa, USA, 2006.
[4] M. M. Hudson, A. C. Mertens, Y. Yasui et al., “Health status ofadult long-term survivors of childhood cancer: a report fromthe childhood cancer survivor study,” Journal of the AmericanMedical Association, vol. 290, no. 12, pp. 1583–1592, 2003.
[5] A. C. Mertens, Y. Yasui, J. P. Neglia et al., “Late mortalityexperience in five-year survivors of childhood and adolescentcancer: the childhood cancer survivor study,” Journal ofClinical Oncology, vol. 19, no. 13, pp. 3163–3172, 2001.
[6] K. C. Oeffinger, A. C. Mertens, C. A. Sklar et al., “Chronichealth conditions in adult survivors of childhood cancer,” NewEngland Journal of Medicine, vol. 355, no. 15, pp. 1572–1582,2006.
[7] S. Aznar, A. L. Webster, A. F. San Juan et al., “Physical activityduring treatment in children with leukemia: a pilot study,”Applied Physiology, Nutrition and Metabolism, vol. 31, no. 4,pp. 407–413, 2006.
[8] M. E. M. Jenney, E. B. Faragher, P. H. M. Jones, and A.Woodcock, “Lung function and exercise capacity in survivorsof childhood leukaemia,” Medical and Pediatric Oncology, vol.24, no. 4, pp. 222–230, 1995.
[9] A. F. San Juan, C. Chamorro-Vina, J. L. Mate-Munoz et al.,“Functional capacity of children with leukemia,” InternationalJournal of Sports Medicine, vol. 29, no. 2, pp. 163–167, 2008.
[10] M. van Brussel, T. Takken, A. Lucia, J. van der Net, and P.J. M. Helders, “Is physical fitness decreased in survivors ofchildhood leukemia? A systematic review,” Leukemia, vol. 19,no. 1, pp. 13–17, 2005.
[11] M. van Brussel, T. Takken, J. Van Der Net et al., “Physicalfunction and fitness in long-term survivors of childhoodleukaemia,” Pediatric Rehabilitation, no. 3, pp. 267–274, 2006.
[12] J. T. Warner, W. Bell, D. K. H. Webb, and J. W. Gregory,“Daily energy expenditure and physical activity in survivors ofchildhood malignancy,” Pediatric Research, vol. 43, no. 5, pp.607–613, 1998.
[13] M. J. Adams, P. H. Hardenbergh, L. S. Constine, and S.E. Lipshultz, “Radiation-associated cardiovascular disease,”Critical Reviews in Oncology/Hematology, vol. 45, no. 1, pp.55–75, 2003.
[14] J. M. Argiles, F. J. Lopez-Soriano, and S. Busquets, “Mecha-nisms to explain wasting of muscle and fat in cancer cachexia,”Current Opinion in Supportive and Palliative Care, vol. 1, no. 4,pp. 293–298, 2007.
[15] K. S. Courneya, “Exercise in cancer survivors: an overview ofresearch,” Medicine and Science in Sports and Exercise, vol. 35,no. 11, pp. 1846–1852, 2003.
10 International Journal of Pediatrics
[16] C. Duggan, L. Bechard, K. Donovan et al., “Changes in restingenergy expenditure among children undergoing allogeneicstem cell transplantation,” American Journal of Clinical Nutri-tion, vol. 78, no. 1, pp. 104–109, 2003.
[17] L. C. M. Kremer, E. C. Van Dalen, M. Offringa, J. Ottenkamp,and P. A. Voute, “Anthracycline-induced clinical heart failurein a cohort of 607 children: long-term follow-up study,”Journal of Clinical Oncology, vol. 19, no. 1, pp. 191–196, 2001.
[18] S. E. Lipshultz, “Exposure to anthracyclines during childhoodcauses cardiac injury,” Seminars in Oncology, vol. 33, no. 3,supplement 8, pp. S8–S14, 2006.
[19] S. E. Lipshultz, S. R. Lipsitz, S. E. Sallan et al., “Chronicprogressive cardiac dysfunction years after doxorubicin ther-apy for childhood acute lymphoblastic leukemia,” Journal ofClinical Oncology, vol. 23, no. 12, pp. 2629–2636, 2005.
[20] R. D. K. S. Liu, M. J. M. Chinapaw, P. C. Huijgens, and W. V.Mechelen, “Physical exercise interventions in haematologicalcancer patients, feasible to conduct but effectiveness to beestablished: a systematic literature review,” Cancer TreatmentReviews, vol. 35, no. 2, pp. 185–192, 2009.
[21] V. G. Marchese, L. A. Chiarello, and B. J. Lange, “Effects ofphysical therapy intervention for children with acute lym-phoblastic leukemia,” Pediatric Blood and Cancer, vol. 42, no.2, pp. 127–133, 2004.
[22] A. F. San Juan, C. Chamorro-Vina, S. Moral et al., “Benefitsof intrahospital exercise training after pediatric bone marrowtransplantation,” International Journal of Sports Medicine, vol.29, no. 5, pp. 439–446, 2008.
[23] A. F. San Juan, S. J. Fleck, C. Chamorro-Vina et al., “Effectsof an intrahospital exercise program intervention for childrenwith leukemia,” Medicine and Science in Sports and Exercise,vol. 39, no. 1, pp. 13–21, 2007.
[24] A. F. S. Juan, K. Wolin, and A. Lucıa, “Physical activityand pediatric cancer survivorship,” Recent Results in CancerResearch, vol. 186, pp. 319–347, 2011.
[25] I. M. Johannsdottir, M. J. Hjermstad, T. Moum et al.,“Increased prevalence of chronic fatigue among survivors ofchildhood cancers: A population-based study,” Pediatric Bloodand Cancer. In press.
[26] K. A. Meeske, S. K. Patel, S. N. Palmer, M. B. Nelson, and A.M. Parow, “Factors associated with health-related quality oflife in pediatric cancer survivors,” Pediatric Blood and Cancer,vol. 49, no. 3, pp. 298–305, 2007.
[27] C. L. Cox, M. Montgomery, K. C. Oeffinger et al., “Promotingphysical activity in childhood cancer survivors,” Cancer, vol.115, no. 3, pp. 642–654, 2009.
[28] K. Y. Wolin, J. R. Ruiz, H. Tuchman, and A. Lucia, “Exercisein adult and pediatric hematological cancer survivors: anintervention review,” Leukemia, vol. 24, no. 6, pp. 1113–1120,2010.
[29] J. Cohen, Statistical Power Analysis for the Behavioral Sciences,Lawrence Erlbaum Associates, Hillsdale, NJ, USA, 1988.
[30] R. Blaauwbroek, M. J. Bouma, W. Tuinier et al., “The effectof exercise counselling with feedback from a pedometer onfatigue in adult survivors of childhood cancer: a pilot study,”Supportive Care in Cancer, pp. 1–8, 2008.
[31] C. Chamorro-Vina, J. R. Ruiz, E. Santana-Sosa et al., “Exerciseduring hematopoietic stem cell transplant hospitalization inchildren,” Medicine and Science in Sports and Exercise, vol. 42,no. 6, pp. 1045–1053, 2010.
[32] S. F. Gohar, M. Comito, J. Price, and V. Marchese, “Feasibilityand parent satisfaction of a physical therapy interventionprogram for children with acute lymphoblastic leukemia in
the first 6 months of medical treatment,” Pediatric Blood andCancer, vol. 56, no. 5, pp. 799–804, 2011.
[33] A. Hartman, M. L. Te Winkel, R. D. Van Beek et al., “Arandomized trial investigating an exercise program to pre-vent reduction of bone mineral density and impairment ofmotor performance during treatment for childhood acutelymphoblastic leukemia,” Pediatric Blood and Cancer, vol. 53,no. 1, pp. 64–71, 2009.
[34] M. R. Keats and S. N. Culos-Reed, “A community-basedphysical activity program for adolescents with cancer (projectTREK): program feasibility and preliminary findings,” Journalof Pediatric Hematology/Oncology, vol. 30, no. 4, pp. 272–280,2008.
[35] A. B. Ladha, K. S. Courneya, G. J. Bell, C. J. Field, and P.Grundy, “Effects of acute exercise on neutrophils in pediatricacute lymphoblastic leukemia survivors: a pilot study,” Journalof Pediatric Hematology/Oncology, vol. 28, no. 10, pp. 671–677,2006.
[36] L. J. Moyer-Mileur, L. Ransdell, and C. S. Bruggers, “Fitnessof children with standard-risk acute lymphoblastic leukemiaduring maintenance therapy: response to a home-basedexercise and nutrition program,” Journal of Pediatric Hema-tology/Oncology, vol. 31, no. 4, pp. 259–266, 2009.
[37] J. R. Ruiz, S. J. Fleck, J. L. Vingren et al., “Preliminary findingsof a 4-month intrahospital exercise training intervention onIGFs and IGFBPs in children with leukemia,” Journal ofStrength and Conditioning Research, vol. 24, no. 5, pp. 1292–1297, 2010.
[38] A. M. Sharkey, A. B. Carey, C. T. Heise, and G. Barber,“Cardiac rehabilitation after cancer therapy in children andyoung adults,” American Journal of Cardiology, vol. 71, no. 16,pp. 1488–1490, 1993.
[39] E. Speyer, A. Herbinet, A. Vuillemin, S. Briancon, and P.Chastagner, “Effect of adapted physical activity sessions inthe hospital on health-related quality of life for children withcancer: a cross-over randomized trial,” Pediatric Blood andCancer, vol. 55, no. 6, pp. 1160–1166, 2010.
[40] T. Takken, P. van der Torre, M. Zwerink et al., “Development,feasibility and efficacy of a community-based exercise trainingprogram in pediatric cancer survivors,” Psycho-Oncology, vol.18, no. 4, pp. 440–448, 2009.
[41] C. H. Yeh, J. P. Man Wai, U. S. Lin, and Y. C. Chiang, “A pilotstudy to examine the feasibility and effects of a home-basedaerobic program on reducing fatigue in children with acutelymphoblastic leukemia,” Cancer Nursing, vol. 34, no. 1, pp.3–12, 2011.
[42] P. S. Hinds, M. Hockenberry, S. N. Rai et al., “Clinical FieldTesting of an Enhanced-Activity Intervention in HospitalizedChildren with Cancer,” Journal of Pain and Symptom Manage-ment, vol. 33, no. 6, pp. 686–697, 2007.
[43] A. F. San Juan, S. J. Fleck, C. Chamorro-Vina et al., “Early-phase adaptations to intrahospital training in strength andfunctional mobility of children with leukemia,” Journal ofStrength and Conditioning Research, vol. 21, no. 1, pp. 173–177,2007.
[44] American College of Sports Medicine, ACSM’s Guidelinesfor Exercise Testing and Prescription, Williams & Wilkins,Philadelphia, Pa, USA, 2000.
[45] E. Golden, B. Beach, and C. Hastings, “The pediatrician andmedical care of the child with cancer,” Pediatric Clinics of NorthAmerica, vol. 49, no. 6, pp. 1319–1338, 2002.
[46] C. S. M. Oude Nijhuis, S. M. G. J. Daenen, E. Vellenga et al.,“Fever and neutropenia in cancer patients: the diagnostic role
International Journal of Pediatrics 11
of cytokines in risk assessment strategies,” Critical Reviews inOncology/Hematology, vol. 44, no. 2, pp. 163–174, 2002.
[47] J. Skinner, J. L. Finlay, P. M. Sondel, and M. E. Trigg,“Infectious complications in pediatric patients undergoingtransplantation with T lymphocyte-depleted bone marrow,”Pediatric Infectious Disease, vol. 5, no. 3, pp. 319–324, 1986.
[48] A. S. Fairey, K. S. Courneya, C. J. Field, and J. R. Mackey,“Physical exercise and immune system function in cancersurvivors: a comprehensive review and future directions,”Cancer, vol. 94, no. 2, pp. 539–551, 2002.
[49] D. M. Chun, C. B. Corbin, and R. P. Pangrazi, “Validation ofcriterion-referenced standards for the mile run and progres-sive aerobic cardiovascular endurance tests,” Research Quar-terly for Exercise and Sport, vol. 71, no. 2, pp. 125–134, 2000.
[50] L. H. Gerber, K. Hoffman, U. Chaudhry et al., “Functionaloutcomes and life satisfaction in long-term survivors ofpediatric sarcomas,” Archives of Physical Medicine and Reha-bilitation, vol. 87, no. 12, pp. 1611–1617, 2006.
[51] V. G. Marchese, L. A. Chiarello, and B. J. Lange, “Strengthand functional mobility in children with Acute LymphoblasticLeukemia,” Medical and Pediatric Oncology, vol. 40, no. 4, pp.230–232, 2003.
[52] K. K. Ness, E. B. Morris, V. G. Nolan et al., “Physical perfor-mance limitations among adult survivors of childhood braintumors,” Cancer, vol. 116, no. 12, pp. 3034–3044, 2010.
[53] N. R. Clanton, J. L. Klosky, C. Li et al., “Fatigue, vitality,sleep, and neurocognitive functioning in adult survivors ofchildhood cancer: a report from the childhood cancer survivorstudy,” Cancer, vol. 117, no. 11, pp. 2559–2568, 2011.
[54] M. J. Hockenberry, M. C. Hooke, M. Gregurich, K. McCarthy,G. Sambuco, and K. Krull, “Symptom clusters in children andadolescents receiving cisplatin, doxorubicin, or ifosfamide,”Oncology Nursing Forum, vol. 37, no. 1, pp. E16–27, 2010.
Submit your manuscripts athttp://www.hindawi.com
Stem CellsInternational
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
MEDIATORSINFLAMMATION
of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Behavioural Neurology
EndocrinologyInternational Journal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
BioMed Research International
OncologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Oxidative Medicine and Cellular Longevity
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
PPAR Research
The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014
Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Journal of
ObesityJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Computational and Mathematical Methods in Medicine
OphthalmologyJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Diabetes ResearchJournal of
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Research and TreatmentAIDS
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Gastroenterology Research and Practice
Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014
Parkinson’s Disease
Evidence-Based Complementary and Alternative Medicine
Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com